Authors: BONI JP DECLEENE SA CEVALLOS WH HICKS DR KORTHBRADLEY JM

Citation: Jp. Boni et al., EFFECTS OF AGE AND GENDER ON THE PHARMACOKINETICS OF BROMFENAC IN HEALTHY-VOLUNTEERS, The Annals of pharmacotherapy, 31(4), 1997, pp. 400-405

Authors: BONI JP CEVALLOS WH DECLEENE S KORTHBRADLEY JM

Citation: Jp. Boni et al., THE INFLUENCE OF BROMFENAC ON THE PHARMACOKINETICS AND PHARMACODYNAMIC RESPONSES TO GLYBURIDE IN DIABETIC SUBJECTS, Pharmacotherapy, 17(4), 1997, pp. 783-790

Authors: ERMER JC BONI JP CEVALLOS WH DECLEENE S BURGHART P RUDNICK MR FRUNCILLO RJ BERNS JS COHEN RM

Citation: Jc. Ermer et al., BROMFENAC DISPOSITION IN PATIENTS WITH IMPAIRED KIDNEY-FUNCTION, Clinical pharmacology and therapeutics, 61(3), 1997, pp. 312-318

Authors: GREENBERGER LM COLLINS KI ANNABLE T BONI JP MAY MK LAI FM KRAMER R CITERALLA RV HALLETT WA POWELL D

Citation: Lm. Greenberger et al., ETHYLPHENYL)THIO]-2(1H)-ISOQUINOLINEHEPTANENITRILE (CL-329,753) - A NOVEL CHEMOSENSITIZING AGENT FOR P-GLYCOPROTEIN-MEDIATED RESISTANCE WITH IMPROVED BIOLOGICAL PROPERTIES COMPARED WITH VERAPAMIL AND CYCLOSPORINE-A, Oncology research, 8(5), 1996, pp. 207-218